← 產業報告目錄

Bioelectric Medicine Market Research Report Information by Type (Implantable Electroceutical Devices and Non-invasive Electroceutical Devices), by Product (Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, And Others), By Application (Arrhythmia, Pain Management, Sensorineural Hearing Loss, Epilepsy, And Others), By End User (Hospitals & Clinics, ASCs, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2030

出版商 Market Research Future產業別 Healthcare & Life Sciences出版日期 2024-08-20頁數 152報告編號 MRFRHC9533CR

授權報價

Single User Price$4,950 USD
Multi User Licence (up to 10 users)$5,950 USD
Enterprisewide Price (Global Site License)$7,250 USD
洽詢購買 申請 Sample

報告摘要

Bioelectric Medicine Market Research Report Information by Type (Implantable Electroceutical Devices and Non-invasive Electroceutical Devices), by Product (Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, And Others), By Application (Arrhythmia, Pain Management, Sensorineural Hearing Loss, Epilepsy, And Others), By End User (Hospitals & Clinics, ASCs, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2030 Market Overview It is anticipated that the Bioelectric Medicine Market will grow at a compound annual growth rate (CAGR) of 6.53% over the forecast period. The growth of the Bioelectric Medicine Market is primarily driven by the increasing prevalence of chronic diseases worldwide and the increasing strategic initiatives of market participants. In 2019, 18 million individuals were diagnosed with rheumatoid arthritis, with 70% of those affected being female and 55% being over the age of 55, according to the World Health Organization. Additionally, Crohn's & Colitis UK predicted that in 2022, one in every 123 individuals in the United Kingdom will have experienced either Crohn's disease or ulcerative colitis.. Nevertheless, the global market's expansion is anticipated to be constrained by the exorbitant cost of bioelectric medical devices. However, the market is expected to generate lucrative opportunities as a result of the increasing investment in bioelectric medicine and the expansion of clinical trials for bioelectric medicine by market participants. The expansion of bioelectric medicine is substantially influenced by the escalating prevalence of chronic diseases worldwide. Chronic diseases, including neurological disorders, inflammatory diseases, metabolic disorders, and chronic pain conditions, significantly burden healthcare systems and negatively affect the quality of life of patients. Some patients may experience adverse effects or experience limited efficacy from conventional treatment methods, such as pharmaceuticals and surgeries. The demand for bioelectric medicine products is on the rise due to the prospective applications of bioelectric medicine in these conditions and the growing prevalence of diseases. For instance, deep brain stimulation (DBS) has demonstrated clinical efficacy in the management of Parkinson's disease symptoms by modulating abnormal neuronal activity. In the same vein, neuromodulation devices such as vagus nerve stimulation (VNS) have been shown to be beneficial in reducing the frequency of seizures in patients with epilepsy. Additionally, the World Health Organization reported in February 2024 that approximately 50 million individuals worldwide were struggling with epilepsy, with nearly 80% of those affected residing in low- and middle-income countries. Market Segment Insights Implantable cardioverter defibrillators, cardiac pacemakers, cochlear implants, spinal cord stimulators, deep brain stimulators, transcutaneous electrical nerve stimulators, sacral nerve stimulators, vagus nerve stimulators, and other devices comprise the global bioelectric medicine segmentation, which is based on product. Implantable electroceutical devices and non-invasive electroceutical devices comprise the bioelectric medicine market segmentation. The Bioelectric Medicine Market has been segmented by application into the following categories: arrhythmia, pain management, sensorineural hearing loss, Parkinson's disease, tremor, melancholy, epilepsy, urinary, and fecal incontinence, among others. The market has been segmented into hospitals, research institutes, and other entities based on the end consumer. Regional Perspectives The market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World by region. The North American bioelectric medicine market held the largest market share of 38.01% in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 4.71% during the forecast period, reaching an estimated USD 16.00 billion by 2030. Nevertheless, the Asia-Pacific region is expected to experience the most rapid growth, with a compound annual growth rate (CAGR) of 8.99% during the forecast period. The bioelectric medicine market in North America is expected to experience sustained growth, which is a promising development. It is anticipated that the market will continue to expand due to investments in healthcare infrastructure and an increasing awareness of advanced medical solutions. Both established companies and emerging entrants are prepared to capitalize on these opportunities by utilizing technological advancements to satisfy the increasing demand for enhanced surgical outcomes. The bioelectric medicine market in Europe accounted for the second-largest market share because of the increasing prevalence of chronic diseases, increasing healthcare expenditure, and technological advancements. In addition, the bioelectric medicine market in Germany is expected to hold the largest market share, while the bioelectric medicine market in France is expected to experience the quickest growth in the European region. Due to the high patient population, the increasing prevalence of chronic diseases, and favorable regulatory policies, the Asia-Pacific bioelectric medicine market is anticipated to experience the most rapid growth from 2023 to 20302. Additionally, the regional market is experiencing growth due to the active expansion of key market participants into this region. Additionally, the bioelectric medicine market in China represented the greatest market share, while the bioelectric medicine market in India is expected to experience the fastest growth in the Asia-Pacific region. Major Players Abbott (US), Boston Scientific Corporation (US), Bortnick (Germany), Aleva Neurotherapeutics (Switzerland), Cochlear Ltd. (Australia), LivaNova PLC (UK), Medtronic (Ireland), Charco Neurotech (UK), ElectroCore, Inc. (US), and Nevro Corp (US) are the key companies in the Bioelectric Medicine market.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 1.1 OVERVIEW 2 MARKET INTRODUCTION 2.1 DEFINITION 2.2 SCOPE OF THE STUDY 2.3 RESEARCH OBJECTIVE 2.4 MARKET STRUCTURE 2.5 ASSUMPTIONS & LIMITATIONS 3 RESEARCH METHODOLOGY 3.1 DATA MINING 3.2 SECONDARY RESEARCH 3.3 PRIMARY RESEARCH 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 3.5 FORECASTING TECHNIQUES 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 3.6.1 BOTTOM-UP APPROACH 3.6.2 TOP-DOWN APPROACH 3.7 DATA TRIANGULATION 3.8 VALIDATION 4 MARKET DYNAMICS 4.1 OVERVIEW 4.2 DRIVERS 4.2.1 INCREASING INCIDENCES OF CHRONIC DISEASES ACROSS THE GLOBE 4.2.2 RISING STRATEGIC INITIATIVES BY MARKET PLAYERS 4.3 RESTRAINTS 4.3.1 HIGH COST ASSOCIATED WITH BIOELECTRIC MEDICINE DEVICES 4.4 OPPORTUNITIES 4.4.1 INCREASING CLINICAL TRIALS FOR BIOELECTRIC MEDICINE 4.4.2 RISING INVESTMENT IN BIOELECTRIC MEDICINE BY MARKET PLAYERS 5 MARKET FACTOR ANALYSIS 5.1 PORTER'S FIVE FORCES MODEL 5.1.1 THREAT OF NEW ENTRANTS 5.1.2 BARGAINING POWER OF SUPPLIERS 5.1.3 THREAT OF SUBSTITUTES 5.1.4 BARGAINING POWER OF BUYERS 5.1.5 INTENSITY OF RIVALRY 5.2 IMPACT OF COVID-19 ON THE GLOBAL BIOELECTRIC MEDICINE MARKET 6 GLOBAL BIOELECTRIC MEDICINE MARKET, BY PRODUCT 6.1 OVERVIEW 6.1.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 6.1.2 CARDIAC PACEMAKERS 6.1.3 COCHLEAR IMPLANTS 6.1.4 SPINAL CORD STIMULATORS 6.1.5 DEEP BRAIN STIMULATORS 6.1.6 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS 6.1.7 SACRAL NERVE STIMULATORS 6.1.8 VAGUS NERVE STIMULATORS 6.1.9 OTHERS 7 GLOBAL BIOELECTRIC MEDICINE MARKET, BY TYPE 7.1 OVERVIEW 7.1.1 IMPLANTABLE ELECTROCEUTICAL DEVICES 7.1.2 NON-INVASIVE ELECTROCEUTICAL DEVICES 8 GLOBAL BIOELECTRIC MEDICINE MARKET, BY APPLICATION 8.1 OVERVIEW 8.1.1 ARRHYTHMIA 8.1.2 PAIN MANAGEMENT 8.1.3 SENSORINEURAL HEARING LOSS 8.1.4 PARKINSON’S DISEASE 8.1.5 TREMOR 8.1.6 DEPRESSION 8.1.7 EPILEPSY 8.1.8 URINARY AND FECAL INCONTINENCE 8.1.9 OTHERS 9 GLOBAL BIOELECTRIC MEDICINE MARKET, BY END USER 9.1 OVERVIEW 9.1.1 HOSPITALS 9.1.2 RESEARCH INSTITUTES 9.1.3 OTHERS 10 GLOBAL BIOELECTRIC MEDICINE MARKET, BY REGION 10.1 OVERVIEW 10.2 NORTH AMERICA 10.2.1 US 10.2.2 CANADA 10.3 EUROPE 10.3.1 GERMANY 10.3.2 FRANCE 10.3.3 UK 10.3.4 ITALY 10.3.5 SPAIN 10.3.6 REST OF EUROPE 10.4 ASIA-PACIFIC 10.4.1 CHINA 10.4.2 INDIA 10.4.3 JAPAN 10.4.4 AUSTRALIA 10.4.5 SOUTH KOREA 10.4.6 REST OF ASIA-PACIFIC 10.5 REST OF THE WORLD 10.5.1 MIDDLE EAST 10.5.2 AFRICA 10.5.3 LATIN AMERICA 11.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL BIOELECTRIC MEDICINE MARKET 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 11.6.1 PRODUCT LAUNCH 11.6.2 PRODUCT APPROVAL 11.6.3 ACQUISITION 11.6.4 INVESTMENT 11.6.5 EXPANSION 11.7 MAJOR PLAYERS FINANCIAL MATRIX 11.7.1 SALES (USD BILLION), 2022 11.7.2 R&D (USD BILLION), 2022 12 COMPANY PROFILES 12.1 ABBOTT 12.1.1 COMPANY OVERVIEW 12.1.2 FINANCIAL ANALYSIS 12.1.3 PRODUCTS OFFERED 12.1.4 KEY DEVELOPMENTS 12.1.5 SWOT ANALYSIS 12.1.6 KEY STRATEGIES 12.2 BOSTON SCIENTIFIC CORPORATION 12.2.1 COMPANY OVERVIEW 12.2.2 FINANCIAL OVERVIEW 12.2.3 PRODUCTS OFFERED 12.2.4 KEY DEVELOPMENTS 12.2.5 SWOT ANALYSIS 12.2.6 KEY STRATEGIES 12.3 ALEVA NEUROTHERAPEUTICS 12.3.1 COMPANY OVERVIEW 12.3.2 FINANCIAL OVERVIEW 12.3.3 PRODUCT OFFERED 12.3.4 KEY DEVELOPMENTS 12.3.5 KEY STRATEGIES 12.4 COCHLEAR LTD. 12.4.1 COMPANY OVERVIEW 12.4.2 FINANCIAL OVERVIEW 12.4.3 PRODUCTS OFFERED 12.4.4 KEY DEVELOPMENTS 12.4.5 SWOT ANALYSIS 12.4.6 KEY STRATEGIES 12.5 LIVANOVA PLC 12.5.1 COMPANY OVERVIEW 12.5.2 FINANCIAL OVERVIEW 12.5.3 PRODUCTS OFFERED 12.5.4 KEY DEVELOPMENTS 12.5.5 KEY STRATEGIES 12.6 MEDTRONIC 12.6.1 COMPANY OVERVIEW 12.6.2 FINANCIAL OVERVIEW 12.6.3 PRODUCTS OFFERED 12.6.4 KEY DEVELOPMENTS 12.6.5 SWOT ANALYSIS 12.6.6 KEY STRATEGIES 12.7 BIOTRONIK 12.7.1 COMPANY OVERVIEW 12.7.2 FINANCIAL OVERVIEW 12.7.3 PRODUCTS OFFERED 12.7.4 KEY DEVELOPMENTS 12.7.5 KEY STRATEGIES 12.8 CHARCO NEUROTECH 12.8.1 COMPANY OVERVIEWS 12.8.2 FINANCIAL OVERVIEW 12.8.3 PRODUCTS OFFERED 12.8.4 KEY DEVELOPMENTS 12.8.5 KEY STRATEGIES 12.9 NEVRO CORP 12.9.1 COMPANY OVERVIEWS 12.9.2 FINANCIAL OVERVIEW 12.9.3 PRODUCTS OFFERED 12.9.4 KEY DEVELOPMENTS 12.9.5 KEY STRATEGIES 12.10 ELECTROCORE, INC 12.10.1 COMPANY OVERVIEWS 12.10.2 FINANCIAL OVERVIEW 12.10.3 PRODUCTS OFFERED 12.10.4 KEY DEVELOPMENTS 12.10.5 SWOT ANALYSIS 12.10.6 KEY STRATEGIES 13 APPENDIX 13.1 REFERENCES 13.2 INTERNATIONAL ASSOCIATION FOR THE STUDY OF PAIN 13.3 AMERICAN PARKINSON DISEASE ASSOCIATION 13.4 PARKINSON'S FOUNDATION 13.5 ANXIETY AND DEPRESSION ASSOCIATION OF AMERICA 13.6 EUROPEAN ALLIANCE AGAINST DEPRESSION 13.7 AMERICAN SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS 13.8 THE AFRICAN SOCIETY FOR REGIONAL ANESTHESIA (AFSRA) 13.9 DEEP BRAIN STIMULATION NURSE ASSOCIATION (DBSNA) 13.10 EUROPEAN SOCIETY OF CARDIOLOGY 13.11 THE COCHLEAR IMPLANT GROUP OF INDIA 13.12 AMERICAN COCHLEAR IMPLANT ALLIANCE 13.13 UNITED SPINAL ASSOCIATION 13.14 AMERICAN SPINAL INJURY ASSOCIATION 13.15 NATIONAL SPINAL CORD INJURY ASSOCIATION 13.16 AMERICAN CLINICAL NEUROPHYSIOLOGY SOCIETY. 13.17 EUROPEAN ACADEMY OF NEUROLOGY (EAN) 13.18 CHILD NEUROLOGY SOCIETY. 13.19 AUSTRALIA EPILEPSY SOCIETY 13.20 RELATED REPORTS
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS TABLE 3 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 4 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2019–2030 (USD BILLION) TABLE 5 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR CARDIAC PACEMAKERS, BY REGION, 2019–2030 (USD BILLION) TABLE 6 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR COCHLEAR IMPLANTS, BY REGION, 2019–2030 (USD BILLION) TABLE 7 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR SPINAL CORD STIMULATORS, BY REGION, 2019–2030 (USD BILLION) TABLE 8 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR DEEP BRAIN STIMULATORS, BY REGION, 2019–2030 (USD BILLION) TABLE 9 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY REGION, 2019–2030 (USD BILLION) TABLE 10 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR SACRAL NERVE STIMULATORS, BY REGION, 2019–2030 (USD BILLION) TABLE 11 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR VAGUS NERVE STIMULATORS, BY REGION, 2019–2030 (USD BILLION) TABLE 12 GLOBAL BIOELECTRIC MEDICINE MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION) TABLE 13 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 14 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR IMPLANTABLE ELECTROCEUTICAL DEVICES, BY REGION, 2019–2030 (USD BILLION) TABLE 15 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR NON-INVASIVE ELECTROCEUTICAL DEVICES, BY REGION, 2019–2030 (USD BILLION) TABLE 16 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 17 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR ARRHYTHMIA, BY REGION, 2019–2030 (USD BILLION) TABLE 18 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR PAIN MANAGEMENT, BY REGION, 2019–2030 (USD BILLION) TABLE 19 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR SENSORINEURAL HEARING LOSS, BY REGION, 2019–2030 (USD BILLION) TABLE 20 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR PARKINSON’S DISEASE, BY REGION, 2019–2030 (USD BILLION) TABLE 21 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR TREMOR, BY REGION, 2019–2030 (USD BILLION) TABLE 22 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR DEPRESSION, BY REGION, 2019–2030 (USD BILLION) TABLE 23 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR EPILEPSY, BY REGION, 2019–2030 (USD BILLION) TABLE 24 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR URINARY AND FECAL INCONTINENCE, BY REGION, 2019–2030 (USD BILLION) TABLE 25 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION) TABLE 26 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 27 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR HOSPITALS, BY REGION, 2019–2030 (USD BILLION) TABLE 28 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR RESEARCH INSTITUTES, BY REGION, 2019–2030 (USD BILLION) TABLE 29 GLOBAL: BIOELECTRIC MEDICINE MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION) TABLE 30 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY REGION, 2019–2030 (USD BILLION) TABLE 31 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET, BY COUNTRY, 2019–2030 (USD BILLION) TABLE 32 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 33 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 34 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 35 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 36 US: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 37 US: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 38 US: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 39 US: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 40 CANADA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 41 CANADA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 42 CANADA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 43 CANADA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 44 EUROPE: BIOELECTRIC MEDICINE MARKET, BY COUNTRY, 2019–2030 (USD BILLION) TABLE 45 EUROPE: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 46 EUROPE: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 47 EUROPE: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 48 EUROPE: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 49 GERMANY: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 50 GERMANY: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 51 GERMANY: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 52 GERMANY: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 53 FRANCE: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 54 FRANCE: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 55 FRANCE: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 56 FRANCE: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 57 UK: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 58 UK: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 59 UK: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 60 UK: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 61 ITALY: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 62 ITALY: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 63 ITALY: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 64 ITALY: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 65 SPAIN: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 66 SPAIN: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 67 SPAIN: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 68 SPAIN: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 69 REST OF EUROPE: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 70 REST OF EUROPE: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 71 REST OF EUROPE: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 72 REST OF EUROPE: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 73 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY COUNTRY, 2019–2030 (USD BILLION) TABLE 74 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 75 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 76 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 77 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 78 CHINA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 79 CHINA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 80 CHINA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 81 CHINA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 82 INDIA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 83 INDIA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 84 INDIA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 85 INDIA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 86 JAPAN: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 87 JAPAN: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 88 JAPAN: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 89 JAPAN: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 90 AUSTRALIA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 91 AUSTRALIA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 92 AUSTRALIA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 93 AUSTRALIA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 94 SOUTH KOREA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 95 SOUTH KOREA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 96 SOUTH KOREA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 97 SOUTH KOREA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 98 REST OF ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 99 REST OF ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 100 REST OF ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 101 REST OF ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 102 REST OT THE WORLD: BIOELECTRIC MEDICINE MARKET, BY REGION, 2019–2030 (USD BILLION) TABLE 103 REST OF THE WORLD: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 104 REST OF THE WORLD: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 105 REST OF THE WORLD: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 106 REST OF THE WORLD: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 107 MIDDLE EAST: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 108 MIDDLE EAST: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 109 MIDDLE EAST: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 110 MIDDLE EAST: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 111 AFRICA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 112 AFRICA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 113 AFRICA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 114 AFRICA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 115 LATIN AMERICA: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2019–2030 (USD BILLION) TABLE 116 LATIN AMERICA: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2019–2030 (USD BILLION) TABLE 117 LATIN AMERICA: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2019–2030 (USD BILLION) TABLE 118 LATIN AMERICA: BIOELECTRIC MEDICINE MARKET, BY END USER, 2019–2030 (USD BILLION) TABLE 119 MAJOR PLAYERS IN THE GLOBAL BIOELECTRIC MEDICINE MARKET TABLE 120 MOST ACTIVE PLAYERS IN THE GLOBAL BIOELECTRIC MEDICINE MARKET TABLE 121 PRODUCT LAUNCH TABLE 122 PRODUCT APPROVAL TABLE 123 ACQUISITION TABLE 124 INVESTMENT TABLE 125 EXPANSION TABLE 126 ABBOTT: PRODUCTS OFFERED TABLE 127 ABBOTT: KEY DEVELOPMENTS TABLE 128 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED TABLE 129 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS TABLE 130 ALEVA NEUROTHERAPEUTICS: PRODUCT OFFERED TABLE 131 ALEVA NEUROTHERAPEUTICS: KEY DEVELOPMENTS TABLE 132 COCHLEAR LTD.: PRODUCTS OFFERED TABLE 133 COCHLEAR LTD.: KEY DEVELOPMENTS TABLE 134 LIVANOVA PLC: PRODUCTS OFFERED TABLE 135 LIVANOVA PLC: KEY DEVELOPMENTS TABLE 136 MEDTRONIC: PRODUCTS OFFERED TABLE 137 MEDTRONIC.: KEY DEVELOPMENTS TABLE 138 BIOTRONIK: PRODUCTS OFFERED TABLE 139 BIOTRONIK.: KEY DEVELOPMENTS TABLE 140 CHARCO NEUROTECH: PRODUCTS OFFERED TABLE 141 CHARCO NEUROTECH: KEY DEVELOPMENTS TABLE 142 NEVRO CORP: PRODUCTS OFFERED TABLE 143 NEVRO CORP: KEY DEVELOPMENTS TABLE 144 ELECTROCORE, INC: PRODUCTS OFFERED TABLE 145 ELECTROCORE, INC: KEY DEVELOPMENTS LIST OF FIGURES FIGURE 1 MARKET SYNOPSIS FIGURE 2 GLOBAL BIOELECTRIC MEDICINE MARKET FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE BIOELECTRIC MEDICINE MARKET FIGURE 5 DRIVER IMPACT ANALYSIS FIGURE 6 RESTRAINT IMPACT ANALYSIS FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL BIOELECTRIC MEDICINE MARKET FIGURE 8 GLOBAL BIOELECTRIC MEDICINE MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2022 TO 2030 (USD BILLION) FIGURE 9 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2022 & 2030 (USD BILLION) FIGURE 10 GLOBAL: BIOELECTRIC MEDICINE MARKET SHARE (%), BY PRODUCT, 2022 FIGURE 11 GLOBAL BIOELECTRIC MEDICINE MARKET, TYPE SEGMENT ATTRACTIVENESS, 2022 TO 2030 (USD BILLION) FIGURE 12 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY TYPE, 2022 & 2030 (USD BILLION) FIGURE 13 GLOBAL: BIOELECTRIC MEDICINE MARKET SHARE (%), BY TYPE, 2022 FIGURE 14 GLOBAL BIOELECTRIC MEDICINE MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2022 TO 2030 (USD BILLION) FIGURE 15 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY APPLICATION, 2022 & 2030 (USD BILLION) FIGURE 16 GLOBAL: BIOELECTRIC MEDICINE MARKET SHARE (%), BY APPLICATION, 2022 FIGURE 17 GLOBAL BIOELECTRIC MEDICINE MARKET, END USER SEGMENT ATTRACTIVENESS, 2022 TO 2030 (USD BILLION) FIGURE 18 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY END USER, 2022 & 2030 (USD BILLION) FIGURE 19 GLOBAL: BIOELECTRIC MEDICINE MARKET SHARE (%), BY END USER, 2022 FIGURE 20 GLOBAL: BIOELECTRIC MEDICINE MARKET, BY REGION, 2022 & 2030 (USD BILLION) FIGURE 21 GLOBAL: BIOELECTRIC MEDICINE MARKET SHARE (%), BY REGION, 2022 FIGURE 22 NORTH AMERICA MARKET ANALYSIS: BIOELECTRIC MEDICINE MARKET, 2019-2030 (USD BILLION) FIGURE 23 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET, BY COUNTRY, 2022 & 2030 (USD BILLION) FIGURE 24 NORTH AMERICA: BIOELECTRIC MEDICINE MARKET SHARE (%), BY COUNTRY, 2022 FIGURE 25 EUROPE MARKET ANALYSIS: BIOELECTRIC MEDICINE MARKET, 2019-2030 (USD BILLION) FIGURE 26 EUROPE: BIOELECTRIC MEDICINE MARKET, BY COUNTRY, 2022 & 2030 (USD BILLION) FIGURE 27 EUROPE: BIOELECTRIC MEDICINE MARKET SHARE (%), BY COUNTRY, 2022 FIGURE 28 ASIA-PACIFIC MARKET ANALYSIS: BIOELECTRIC MEDICINE MARKET, 2019-2030 (USD BILLION) FIGURE 29 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET, BY COUNTRY, 2022 & 2030 (USD BILLION) FIGURE 30 ASIA-PACIFIC: BIOELECTRIC MEDICINE MARKET SHARE (%), BY COUNTRY, 2022 FIGURE 31 REST OF THE WORLD MARKET ANALYSIS: BIOELECTRIC MEDICINE MARKET, 2019-2030 (USD BILLION) FIGURE 32 REST OT THE WORLD: BIOELECTRIC MEDICINE MARKET, BY REGION, 2022 & 2030 (USD BILLION) FIGURE 33 REST OT THE WORLD: BIOELECTRIC MEDICINE MARKET SHARE (%), BY REGION, 2022 FIGURE 34 BENCHMARKING OF MAJOR COMPETITORS FIGURE 35 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL BIOELECTRIC MEDICINE MARKET FIGURE 36 GLOBAL BIOELECTRIC MEDICINE MARKET: COMPETITIVE LANDSCAPE FIGURE 37 SALES, 2022 FIGURE 38 R&D, 2022 FIGURE 39 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT FIGURE 40 ABBOTT: SWOT ANALYSIS FIGURE 41 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT FIGURE 42 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS FIGURE 43 COCHLEAR LTD.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 44 COCHLEAR LTD.: SWOT ANALYSIS FIGURE 45 LIVANOVA PLC: FINANCIAL OVERVIEW SNAPSHOT FIGURE 46 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT FIGURE 47 MEDTRONIC: SWOT ANALYSIS FIGURE 48 NEVRO CORP: FINANCIAL OVERVIEW SNAPSHOT FIGURE 49 ELECTROCORE, INC: FINANCIAL OVERVIEW SNAPSHOT FIGURE 50 ELECTROCORE, INC: SWOT ANALYSIS

提及公司

Abbott (US)Boston Scientific Corporation (US)Bortnick (Germany)Aleva Neurotherapeutics (Switzerland)Cochlear Ltd. (Australia)LivaNova PLC (UK)Medtronic (Ireland)Charco Neurotech (UK)ElectroCoreInc. (US)and Nevro Corp (US)

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們